Pfizer and Cipla have reached a price-cut agreement, brokered by the American Cancer Society, to dramatically reduce prices for 16 common chemotherapy drugs in six African countries. As part of the initiative, IBM will simplify treatment guidelines through its Watson supercomputing program.
Pfizer, Cipla partner with American Cancer Society to cut drug prices in Africa
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.